166 related articles for article (PubMed ID: 37291891)
1. Pharmacological management of digital ulcers in systemic sclerosis - what is new?
Herrick AL; Philobos M
Expert Opin Pharmacother; 2023; 24(10):1159-1170. PubMed ID: 37291891
[TBL] [Abstract][Full Text] [Related]
2. Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives.
Sagonas I; Daoussis D
Clin Rheumatol; 2023 Oct; 42(10):2589-2599. PubMed ID: 36847929
[TBL] [Abstract][Full Text] [Related]
3. A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis: A Narrative Review.
Hughes M; Allanore Y; El Aoufy K; Denton CP; Khanna D; Krieg T; Matucci-Cerinic M
JAMA Dermatol; 2021 Jul; 157(7):851-858. PubMed ID: 34037677
[TBL] [Abstract][Full Text] [Related]
4. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
Matucci-Cerinic M; Denton CP; Furst DE; Mayes MD; Hsu VM; Carpentier P; Wigley FM; Black CM; Fessler BJ; Merkel PA; Pope JE; Sweiss NJ; Doyle MK; Hellmich B; Medsger TA; Morganti A; Kramer F; Korn JH; Seibold JR
Ann Rheum Dis; 2011 Jan; 70(1):32-8. PubMed ID: 20805294
[TBL] [Abstract][Full Text] [Related]
5. A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis.
Shenavandeh S; Sepaskhah M; Dehghani S; Nazarinia M
Clin Rheumatol; 2022 Jan; 41(1):95-104. PubMed ID: 34471968
[TBL] [Abstract][Full Text] [Related]
6. Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case.
Blaise S; Roustit M; Forli A; Imbert B; Cracowski JL
Int Wound J; 2017 Dec; 14(6):978-981. PubMed ID: 28303689
[TBL] [Abstract][Full Text] [Related]
7. Digital ulcers in systemic sclerosis.
Hughes M; Herrick AL
Rheumatology (Oxford); 2017 Jan; 56(1):14-25. PubMed ID: 27094599
[TBL] [Abstract][Full Text] [Related]
8. Digital ulcer debridement in systemic sclerosis: a systematic literature review.
Hughes M; Alcacer-Pitarch B; Gheorghiu AM; Praino E; Sandler RD; Tavor Y; Bruni C; Matucci-Cerinic M
Clin Rheumatol; 2020 Mar; 39(3):805-811. PubMed ID: 31955323
[TBL] [Abstract][Full Text] [Related]
9. A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients.
Silva I; Almeida J; Vasconcelos C
Autoimmun Rev; 2015 Feb; 14(2):140-52. PubMed ID: 25449678
[TBL] [Abstract][Full Text] [Related]
10. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020.
Maltez N; Hughes M; Brown E; Hickey V; Park H; Shea B; Herrick AL; Pauling JD; Proudman S; Merkel PA
Semin Arthritis Rheum; 2021 Jun; 51(3):640-643. PubMed ID: 33947582
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
Silva C; Solanki KK; White DHN
Rheumatol Immunol Res; 2022 Jun; 3(2):84-89. PubMed ID: 36465326
[TBL] [Abstract][Full Text] [Related]
12. Raynaud's phenomenon and digital ulcers: advances in evaluation and management.
Herrick AL
Curr Opin Rheumatol; 2021 Nov; 33(6):453-462. PubMed ID: 34420003
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the pathogenesis and management of Raynaud's phenomenon and digital ulcers.
Herrick AL
Curr Opin Rheumatol; 2016 Nov; 28(6):577-85. PubMed ID: 27541182
[TBL] [Abstract][Full Text] [Related]
14. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
Abou-Raya A; Abou-Raya S; Helmii M
J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
[TBL] [Abstract][Full Text] [Related]
15. Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
Ross L; Maltez N; Hughes M; Schoones JW; Baron M; Chung L; Giuggioli D; Moinzadeh P; Suliman YA; Campochiaro C; Allanore Y; Denton CP; Distler O; Frech T; Furst DE; Khanna D; Krieg T; Kuwana M; Matucci-Cerinic M; Pope J; Alunno A
Rheumatology (Oxford); 2023 Dec; 62(12):3785-3800. PubMed ID: 37335850
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.
Motegi S; Yamada K; Toki S; Uchiyama A; Kubota Y; Nakamura T; Ishikawa O
J Dermatol; 2016 Jan; 43(1):56-62. PubMed ID: 26173902
[TBL] [Abstract][Full Text] [Related]
17. Preliminary Clinical and Laser Speckle Contrast Analysis Data on Selexipag Efficacy for the Treatment of Digital Vasculopathy in Systemic Sclerosis.
Di Battista M; Della Rossa A; Da Rio M; De Mattia G; Morganti R; Mosca M
J Rheumatol; 2023 Aug; 50(8):1029-1031. PubMed ID: 37003608
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adjunctive ambrisentan treatment for digital ulcers in patients with systemic sclerosis: a case series study
Xu B; Yu Y; Liang J; Xu G; Chen W; Lin J; Hu S
J Dermatolog Treat; 2023 Dec; 34(1):2276046. PubMed ID: 38073230
[No Abstract] [Full Text] [Related]
19. Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).
Mecoli CA; Perin J; Van Eyk JE; Zhu J; Fu Q; Allmon AG; Rao Y; Zeger S; Wigley FM; Hummers LK; Shah AA
Clin Rheumatol; 2020 Apr; 39(4):1199-1205. PubMed ID: 31858338
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Vascular Complications in Systemic Sclerosis: What Is the Best Approach to Diagnosis and Management of Renal Crisis and Digital Ulcers?
Hughes M; Herrick AL; Hudson M
Rheum Dis Clin North Am; 2023 May; 49(2):263-277. PubMed ID: 37028834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
